(Fabrinet IPO added.)
NEW YORK (TheStreet) -- Two more privately-held companies are looking to enter the market, Ironwood Pharmaceuticals and Fabrinet. Ironwood is planning an initial public offering of up to $172.5 million in stock. The company is developing linaclotide, a treatment for irritable bowel syndrome, and will use proceeds from the offering to fund the drug, as well as other projects. Ironwood plans to trade under the ticker "IRWD" on the Nasdaq. Fabrinet, which manufactures components for optical communication systems and other products, expects to raise $150 million in its IPO. It has applied for listing on the new York Stock Exchange under the ticker "FN." Last week, five companies came to market in IPOs that totaled $889.5 million.- Loading Comments...
- Loading Comments...
Recent Comments
Featured Photo Galleries
Connect with TheStreet
 |
 |
-
Swiss bank UBS returns to profit
BBC
-
China's Auto Sales Rise Sharply
The Wall Street Journal.
-
U.S. Stocks Rally on Growing Prospects for Bailout of Greece
BusinessWeek Online
-
Google Adds 'Buzz' to Gmail
The Wall Street Journal.
-
Japan Airlines Decides to Stick With American Airlines
New York Times
-
Why fret about Greece?
The Economist
-
Stiglitz Sees No Greek Default as ‘Speculative Attacks’ Persist
BusinessWeek Online
-
Opels Strategy Has Fewer Jobs and Less Capacity
New York Times
-
Tuesday Reads
The Big Picture
-
BLS: Few Job Openings in December
Calculated Risk
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,058.64 | 1,070.52 | 2,150.87 | 36.33 |
Oil *
72.02
|
|
UP
150.25
|
UP
13.78
|
UP
24.82
|
UP
0.41
|
10 Yr
3.63%
SPDR Gold
105.45
|
|
+1.52%
|
+1.30%
|
+1.17%
|
+1.14%
|
Data delayed 20 minutes |
More From TheStreet
Latest Headlines
Brokerage Partners
Sponsored Links
